These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

686 related items for PubMed ID: 8403196

  • 1. The sensitivity to DNA topoisomerase inhibitors in L5178Y lymphoma strains is not related to a primary defect of DNA topoisomerases.
    Lanza A, Tornaletti S, Stefanini M, Evans HH, Ricanati M, Astaldi Ricotti GC, Pedrini AM.
    Carcinogenesis; 1993 Sep; 14(9):1759-63. PubMed ID: 8403196
    [Abstract] [Full Text] [Related]

  • 2. Relationship between topoisomerase II and radiosensitivity in mouse L5178Y lymphoma strains.
    Evans HH, Ricanati M, Horng MF, Mencl J.
    Mutat Res; 1989 Jan; 217(1):53-63. PubMed ID: 2536134
    [Abstract] [Full Text] [Related]

  • 3. Reduced sensitivity to camptothecin of topoisomerase I from a L5178Y mouse lymphoma subline sensitive to X-radiation.
    Kowalska-Loth B, Staron K, Buraczewska I, Szumiel I, Kapiszewska M, Lange CS.
    Biochim Biophys Acta; 1993 Feb 20; 1172(1-2):117-23. PubMed ID: 8382526
    [Abstract] [Full Text] [Related]

  • 4. The sensitivity to camptothecin of DNA topoisomerase I in L5178Y-S lymphoma cells.
    Staron K, Kowalska-Loth B, Szumiel I.
    Carcinogenesis; 1994 Dec 20; 15(12):2953-5. PubMed ID: 8001262
    [Abstract] [Full Text] [Related]

  • 5. Sensitivity to inhibitors of type II topoisomerases from mouse L5178Y lymphoma strains that are resistant or sensitive to X-radiation.
    Staron K, Kowalska-Loth B, Szumiel I, Buraczewska I.
    Mutat Res; 1993 Feb 20; 285(2):175-9. PubMed ID: 7678889
    [Abstract] [Full Text] [Related]

  • 6. Discrepancy between the initial DNA damage and cell survival after camptothecin treatment in two murine lymphoma L5178Y sublines.
    Gradzka I, Szumiel I.
    Cell Biochem Funct; 1996 Sep 20; 14(3):163-71. PubMed ID: 8888569
    [Abstract] [Full Text] [Related]

  • 7. Altered topoisomerase I and II activities in suramin-resistant lung fibrosarcoma cells.
    Lelièvre S, Benchokroun Y, Larsen AK.
    Mol Pharmacol; 1995 May 20; 47(5):898-906. PubMed ID: 7746278
    [Abstract] [Full Text] [Related]

  • 8. Quantification of topoisomerase-DNA complexes in leukemia cells from patients undergoing therapy with a topoisomerase-directed agent.
    Ellis AL, Nowak B, Plunkett W, Zwelling LA.
    Cancer Chemother Pharmacol; 1994 May 20; 34(3):249-56. PubMed ID: 8004759
    [Abstract] [Full Text] [Related]

  • 9. DNA topoisomerase I as a site of action for 10-hydroxycamptothecin in human promyelocytic leukemia cells.
    Ling YH, Andersson BS, Nelson JA.
    Cancer Biochem Biophys; 1990 Jan 20; 11(1):23-30. PubMed ID: 2159843
    [Abstract] [Full Text] [Related]

  • 10. Potentiation of topoisomerase inhibitor-induced DNA strand breakage and cytotoxicity by tumor necrosis factor: enhancement of topoisomerase activity as a mechanism of potentiation.
    Utsugi T, Mattern MR, Mirabelli CK, Hanna N.
    Cancer Res; 1990 May 01; 50(9):2636-40. PubMed ID: 2158396
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Differential requirement of DNA replication for the cytotoxicity of DNA topoisomerase I and II inhibitors in Chinese hamster DC3F cells.
    Holm C, Covey JM, Kerrigan D, Pommier Y.
    Cancer Res; 1989 Nov 15; 49(22):6365-8. PubMed ID: 2553254
    [Abstract] [Full Text] [Related]

  • 17. Altered topoisomerase I activity and recombination activating gene expression in a human leukemia cell line resistant to doxorubicin.
    Riou JF, Grondard L, Petitgenet O, Abitbol M, Lavelle F.
    Biochem Pharmacol; 1993 Sep 01; 46(5):851-61. PubMed ID: 8396937
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Inhibition of replicon initiation in human cells following stabilization of topoisomerase-DNA cleavable complexes.
    Kaufmann WK, Boyer JC, Estabrooks LL, Wilson SJ.
    Mol Cell Biol; 1991 Jul 01; 11(7):3711-8. PubMed ID: 1646393
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 35.